Anesthesia and Respiratory Devices: Global Markets

The global market for anesthesia and respiratory devices is expected to grow from $51.9 billion in 2025 and is projected to reach $74.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2025 to 2030.

Anesthesia and respiratory devices are devices used to support or control breathing, maintain airway patency, deliver anesthetic gases for surgery or assist patients with respiratory insufficiency or sleeprelated breathing disorders. These devices are designed to administer anesthesia and provide respiratory support to patients, ensuring safety and comfort during medical procedures. These devices have revolutionized anesthesia and respiratory care, enabling healthcare professionals to manage conditions effectively.

The primary companies in the global market for anesthesia and respiratory devices are Roche, Koninklijke Philips N.V., GE HealthCare, ResMed and Teleflex. These companies focus on developing anesthesia and respiratory devices for patient monitoring, ventilators, anesthesia masks and other disposable products.

Report Scope

The report provides an overview of the global markets for anesthesia and respiratory devices and analyzes market trends. The report includes global revenue ($ million) for base year 2024, estimated data for 2025 and a forecast through 2030. The market is segmented based on products and region. The regions covered in this study include North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, with a focus on major countries in these regions.

The report examines the driving trends and challenges in the market and vendor landscapes. It also analyzes environmental, social and governance (ESG) developments and discusses the regulations and emerging technologies used in anesthesia and respiratory devices.

The report concludes with an analysis of the competitive landscape, providing the ranking/share of key global markets for companies producing anesthesia and respiratory devices. A dedicated section of company profiles for major anesthesia and respiratory devices is also included.

The report includes:

33 data tables and 73 additional tables
An analysis of the global market for anesthesia and respiratory devices
Analyses of the global market trends, with historic revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
Estimates of the market’s size and revenue prospects, along with a corresponding market share analysis on the basis of product type and sub-type, and region
Facts and figures pertaining to market dynamics, technological advancements, regulations, industry structure and the impacts of macroeconomic variables
Insights derived from Porter’s Five Forces model, global supply chain and SWOT analyses
Patent analysis, and emerging trends and developments in patent activity
An overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., ResMed, Teleflex Inc., GE Healthcare, and Medtronic

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Introduction
Types of Anesthesia and Respiratory Devices
Trends in Anesthesiology
Key Trends in Anesthesia Devices
Key Trends in Respiratory Devices
Key Statistical Research Highlights in Anesthesia and Respiratory Devices
Macroeconomic Factors Analysis
Porter's Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of New Entrants
Threat of Substitutes
Competitive Rivalry and Degree of Competition

Chapter 3 Market Dynamics

Key Takeaways
Market Drivers
Increase in the Number of Surgical Procedures
Growing Aging Population Worldwide
Demand for Devices to Treat Sleep Disorders
Impact of Air Pollution on Respiratory Health
Increase in COPD Cases
Market Restraints
Side Effects of Anesthesia and Its Devices
High Cost of Advanced Devices
Shortage of Trained Personnel
Restrictions and Recalls
Market Opportunities
New Products and Apps Launches
Digitalization in Anesthesia and Respiratory Devices

Chapter 4 Industry Outlook: Regulatory Framework

Regulatory Framework in the U.S.
Classification
Market Authorization
Post-Market Surveillance
Regulatory Framework in the EU
Classification
Market Authorization
Unique Device Identification
Post-Market Surveillance
Regulatory Framework in Japan
Classification
Market Authorization
Post-Market Surveillance
Regulatory Framework in India
Classification
Market Authorization
Post-Market Surveillance
Regulatory Framework in China
Classification
Post-Market Surveillance

Chapter 5 Emerging Technologies and Developments

Overview
Closed-Loop Anesthesia Systems
Emergence of Total Intravenous Anesthesia
Advanced Ventilation Techniques
Ultrasound-Guided Anesthesia
Patent Analysis
Key Findings

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Market Breakdown by Product
Key Takeaways
Respiratory Devices
Respiratory Measurement Devices
Anesthesia Machines
Airway Management Devices
Sleep Apnea Devices
Respiratory Disposables
Anesthesia Disposables
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa

Chapter 7 Competitive Intelligence

Key Takeaways
Competitive Landscape
Global Market Shares of Leading Companies
Key Developments and Strategies
Partnerships and Collaborations
Business Expansions
Product Launches, Enhancements and Expansions
Acquisitions
SWOT Analysis of Anesthesia and Respiratory Device Competitors
Strengths
Weakness
Opportunities
Threats

Chapter 8 Sustainability in the Anesthesia and Respiratory Devices Industry

Introduction
Snapshot on the Functions of ESG
Key Challenges to Implementing ESG Practices
ESG Ranking
ESG Practices in the Anesthesia and Respiratory Devices Industry
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks

Chapter 9 Appendix

Research Methodology
References
Abbreviations
Company Profiles
ADVACARE PHARMA
AMBU A/S
B. BRAUN SE
BD
DRÄGERWERK AG & CO. KGAA.
F. HOFFMANN-LA ROCHE LTD.
FISHER & PAYKEL HEALTHCARE LTD.
GE HEALTHCARE
ICU MEDICAL INC.
KONINKLIJKE PHILIPS N.V.
MASIMO
MEDTRONIC
MERA
RESMED
TELEFLEX INC.
Few Emerging Startups/Market Disruptors

List of Tables

Summary Table: Global Market for Anesthesia and Respiratory Devices, by Region, Through 2030
Table 1: Anesthesia Machines, Product Matrix, 2025
Table 2: Ventilator Equipment and Related Accessories and Services, Product Matrix, 2025
Table 3: Macroeconomic Factors Analysis
Table 4: Porter’s Five Forces Analysis
Table 5: Regional Anesthesia Techniques for Cancer Patients
Table 6: Cardiac Surgical Volumes per 100,000 Population, 2024
Table 7: Causes of Sleep Disorder in ResMed Surveyed Countries, 2024
Table 8: Recall of Anesthesia and Respiratory Devices, 2025
Table 9: Product Approvals and Launches, 2022-2025
Table 10: Philips Devices Recalled by the FDA, 2024
Table 11: ResMed Devices Recalled by the FDA, 2024
Table 12: Anesthesia-Related Regulatory Bodies and Societies in Europe, 2024
Table 13: Regulatory Requirements in Japan
Table 14: Regulation of Anesthesia and Respiratory Devices in India
Table 15: Published Patents for Anesthesia and Respiratory Devices, 2024 and 2025
Table 16: Global Market for Anesthesia and Respiratory Devices, by Product, Through 2030
Table 17: Global Market for Respiratory Devices, by Region, Through 2030
Table 18: Global Market for Respiratory Measurement Devices, by Region, Through 2030
Table 19: Global Market for Anesthesia Machines, by Region, Through 2030
Table 20: Applications and Ethical Considerations on Anesthesia Use
Table 21: Global Market for Airway Management Devices, by Region, Through 2030
Table 22: Everyday Use of Airway Management Devices
Table 23: Global Market for Sleep Apnea Devices, by Region, Through 2030
Table 24: Global Market for Respiratory Disposables, by Region, Through 2030
Table 25: Global Market for Anesthesia Disposables, by Region, Through 2030
Table 26: Global Market for Anesthesia and Respiratory Devices, by Region, Through 2030
Table 27: North American Market for Anesthesia and Respiratory Devices, by Product, Through 2030
Table 28: North American Market for Anesthesia and Respiratory Devices, by Country, Through 2030
Table 29: European Market for Anesthesia and Respiratory Devices, by Product, Through 2030
Table 30: European Market for Anesthesia and Respiratory Devices, by Country, Through 2030
Table 31: Asia-Pacific Market for Anesthesia and Respiratory Devices, by Product, Through 2030
Table 32: Asia-Pacific Market for Anesthesia and Respiratory Devices, by Country, Through 2030
Table 33: South American Market for Anesthesia and Respiratory Devices, by Product, Through 2030
Table 34: South American Market for Anesthesia and Respiratory Devices, by Country/Region, Through 2030
Table 35: Total Cases of Respiratory Viruses, 2020-2024
Table 36: MEA Market for Anesthesia and Respiratory Devices, by Product, Through 2030
Table 37: MEA Market for Anesthesia and Respiratory Devices, by Region, Through 2030
Table 38: African Countries with CTS Procedures, 2024
Table 39: Key Partnerships and Collaborations in the Anesthesia and Respiratory Devices Market, 2022-2024
Table 40: Business Expansion Activities in the Anesthesia and Respiratory Devices Market, 2022-2025
Table 41: Product Launches and Product Approvals in the Anesthesia and Respiratory Devices Market, 2022-2025
Table 42: Key Acquisitions in the Anesthesia and Respiratory Devices Market, 2022-2024
Table 43: ESG Rankings for the Anesthesia and Respiratory Devices Industry, 2025*
Table 44: ESG Practices: Environmental Performance
Table 45: ESG Practices: Social Performance
Table 46: ESG Practices: Governance Performance
Table 47: Abbreviations Used in the Report
Table 48: AdvaCare Pharma: Company Snapshot
Table 49: AdvaCare Pharma: Product Portfolio
Table 50: Ambu A/S: Company Snapshot
Table 51: Ambu A/S: Financial Performance, FY 2023 and 2024
Table 52: Ambu A/S: Product Portfolio
Table 53: Ambu A/S: News/Key Developments, 2022-2025
Table 54: B. Braun SE.: Company Snapshot
Table 55: B. Braun SE.: Financial Performance, FY 2023 and 2024
Table 56: B. Braun SE: Product Portfolio
Table 57: B. Braun SE: News/Key Developments, 2024-2025
Table 58: BD: Company Snapshot
Table 59: BD: Financial Performance, FY 2023 and 2024
Table 60: BD: Product Portfolio
Table 61: BD: News/Key Developments, 2023-2024
Table 62: Drägerwerk AG & Co. KGaA.: Company Snapshot
Table 63: Drägerwerk AG & Co. KGaA.: Financial Performance, FY 2023 and 2024
Table 64: Drägerwerk AG & Co. KGaA.: Product Portfolio
Table 65: Drägerwerk AG & Co. KGaA.: News/Key Developments, 2023-2025
Table 66: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 67: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 68: F. Hoffmann-La Roche Ltd: Product Portfolio
Table 69: F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021-2024
Table 70: Fisher & Paykel Healthcare Ltd.: Company Snapshot
Table 71: Fisher & Paykel Healthcare Ltd.: Financial Performance, FY 2023 and 2024
Table 72: Fisher & Paykel Healthcare Ltd.: Product Portfolio
Table 73: Fisher & Paykel Healthcare Ltd.: News/Key Developments, 2024-2025
Table 74: GE HealthCare: Company Snapshot
Table 75: GE HealthCare: Financial Performance, FY 2023 and 2024
Table 76: GE HealthCare: Product Portfolio
Table 77: GE Healthcare: News/Key Developments, 2022-2024
Table 78: ICU Medical Inc.: Company Snapshot
Table 79: ICU Medical Inc.: Financial Performance, FY 2023 and 2024
Table 80: ICU Medical Inc.: Product Portfolio
Table 81: ICU Medical Inc.: News/Key Developments, 2022-2025
Table 82: Koninklijke Philips N.V.: Company Snapshot
Table 83: Koninklijke Philips N.V.: Financial Performance, FY 2023 and 2024
Table 84: Koninklijke Philips N.V.: Product Portfolio
Table 85: Koninklijke Philips N.V.: News/Key Developments, 2024
Table 86: Masimo: Company Snapshot
Table 87: Masimo: Financial Performance, FY 2023 and 2024
Table 88: Masimo: Product Portfolio
Table 89: Masimo: News/Key Developments, 2023-2024
Table 90: Medtronic: Company Snapshot
Table 91: Medtronic: Financial Performance, FY 2022 and 2023
Table 92: Medtronic: Product Portfolio
Table 93: Medtronic: News/Key Developments, 2022-2024
Table 94: MERA: Company Snapshot
Table 95: MERA: Product Portfolio
Table 96: MERA: News/Key Developments, 2021
Table 97: ResMed: Company Snapshot
Table 98: Resmed: Financial Performance, FY 2022 and 2023
Table 99: ResMed: Product Portfolio
Table 100: ResMed: News/Key Developments, 2022-2025
Table 101: Teleflex Inc.: Company Snapshot
Table 102: Teleflex Inc.: Financial Performance, FY 2024 and 2024
Table 103: Teleflex Inc.: Product Portfolio
Table 104: Teleflex Inc.: News/Key Developments, 2023-2025
Table 105: List of Emerging Startups

List of Figures

Summary Figure: Global Market Shares of Anesthesia and Respiratory Devices, by Region, 2024
Figure 1: Collaborative Research Highlights of Anesthesia and Cardiothoracic Research, 2025
Figure 2: Surgical Volume per Year (Reporting Countries), 2020-2023
Figure 3: Market Dynamics of Anesthesia and Respiratory Devices
Figure 4: Transplantation of Organs, 2024
Figure 5: ResMed Sleep Survey, 2024
Figure 6: Diseases Occurring from Air Pollution, 2024
Figure 7: Average Years of Life Lost Due to Long-Term Exposure to PM2.5 in Europe, 2025
Figure 8: Global Prevalence of COPD, by Sex and Age Group, 2024
Figure 9: Global Prevalence of COPD, by Country, 2024
Figure 10: 510(k) Submission Pathways for Anesthesia and Respiratory Devices
Figure 11: Emerging Technologies in the Anesthesia and Respiratory Devices Market
Figure 12: Global Market Shares of Anesthesia and Respiratory Devices, by Product, 2024
Figure 13: Global Market Shares of Respiratory Devices, by Region, 2024
Figure 14: Global Market Shares of Respiratory Measurement Devices, by Region, 2024
Figure 15: Global Market Shares of Anesthesia Machines, by Region, 2024
Figure 16: Global Market Shares of Airway Management Devices, by Region, 2024
Figure 17: Global Market Shares of Sleep Apnea Devices, by Region, 2024
Figure 18: Global Market Shares of Respiratory Disposables, by Region, 2024
Figure 19: Companies Manufacturing Respiratory Disposables
Figure 20: Global Market Shares of Anesthesia Disposables, by Region, 2024
Figure 21: Global Market Shares of Anesthesia and Respiratory Devices, by Region, 2024
Figure 22: North American Market Shares of Anesthesia and Respiratory Devices, by Country, 2024
Figure 23: COPD Occurrence in the U.S States, 2023
Figure 24: European Market Shares of Anesthesia and Respiratory Devices, by Country, 2024
Figure 25: Emergency Hospital Admissions in England, 2024
Figure 26: Asia-Pacific Market Shares of Anesthesia and Respiratory Devices, by Country, 2024
Figure 27: South American Market Shares of Anesthesia and Respiratory Devices, by Country/Region, 2024
Figure 28: MEA Market Shares of Anesthesia and Respiratory Devices, by Region, 2024
Figure 29: Company Market Share Analysis, 2024
Figure 30: SWOT Analysis of Competitors in the Anesthesia and Respiratory Devices Market, 2024
Figure 31: Key ESG Trends in the Anesthesia and Respiratory Devices Industry
Figure 32: Key ESG Trends in the Anesthesia and Respiratory Devices Industry
Figure 33: Ambu A/S.: Revenue Shares, by Business Unit, FY 2024
Figure 34: Ambu A/S.: Revenue Shares, by Country/Region, FY 2024
Figure 35: B. Braun SE: Revenue Shares, by Business Unit, FY 2024
Figure 36: B. Braun SE: Revenue Shares, by Country/Region, FY 2024
Figure 37: BD: Revenue Shares, by Business Unit, FY 2024
Figure 38: BD: Revenue Shares, by Country/Region, FY 2024
Figure 39: Drägerwerk AG & Co. KGaA.: Revenue Shares, by Business Unit, FY 2024
Figure 40: Drägerwerk AG & Co. KGaA.: Revenue Shares, by Country/Region, FY 2024
Figure 41: F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2024
Figure 42: F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 43: Fisher & Paykel Healthcare Ltd.: Revenue Shares, by Business Segment, FY 2024
Figure 44: Fisher & Paykel Healthcare Ltd.: Revenue Shares, by Country/Region, FY 2024
Figure 45: GE HealthCare: Revenue Shares, by Business Unit, FY 2024
Figure 46: GE HealthCare: Revenue Shares, by Country/Region, FY 2024
Figure 47: ICU Medical Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 48: ICU Medical Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 49: Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2024
Figure 50: Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2024
Figure 51: Masimo: Revenue Shares, by Business Unit, FY 2024
Figure 52: Masimo: Revenue Shares, by Country/Region, FY 2024
Figure 53: Medtronic: Revenue Shares, by Business Unit, FY 2023
Figure 54: Medtronic: Revenue Shares, by Country/Region, FY 2023
Figure 55: ResMed: Revenue Shares, by Business Unit, FY 2023
Figure 56: ResMed: Revenue Shares, by Country/Region, FY 2023
Figure 57: Teleflex Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 58: Teleflex Inc.: Revenue Shares, by Country/Region, FY 2024

Companies Mentioned

The companies profiled in this Anesthesia and Respiratory Devices market report include:

Advacare Pharma
Ambu A/S
B. Braun SE
BD
Drägerwerk AG & Co. KGaA
F. Hoffmann-La Roche Ltd.
Fisher & Paykel Healthcare Ltd.
GE Healthcare
ICU Medical Inc.
Koninklijke Philips N.V.
Masimo
Medtronic
Mera
Resmed
Teleflex Inc.

Table Information

Report Attribute	Details
No. of Pages	178
Published	August 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 51.9 Billion
Forecasted Market Value ( USD ) by 2030	$ 74.8 Billion
Compound Annual Growth Rate	7.6%
Regions Covered	Global
No. of Companies Mentioned	16

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4115EUR$4,650USD£3,558GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€4937EUR$5,580USD£4,269GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5925EUR$6,696USD£5,123GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€7110EUR$8,035USD£6,148GBP

Report Scope

The report includes:

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Anesthesia & Respiratory Devices - Global Strategic Business Report

Anesthesia and Respiratory Devices Market Report by Product Type, End User, Region 2025-2033

Anesthesia and Respiratory Devices Market Report 2025

Anesthesia & Respiratory Devices Market by Product Type, Application, End User, Technology, Patient Age Group, Mobility, Distribution Channel, Power Source, Mode, Pricing Tier - Global Forecast 2025-2030

Anesthesia and Respiratory Devices Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type